[Federal Register: July 6, 2010 (Volume 75, Number 128)]
[Notices]
[Page 38863-38864]
[DOCID:fr06jy10-119]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Tenth Meeting: Joint RTCA Special Committee 213: EUROCAE WG-79:
Enhanced Flight Vision Systems/Synthetic Vision Systems (EFVS/SVS)

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of Joint RTCA Special Committee 213: EUROCAE WG-79:
Enhanced Flight Vision Systems/Synthetic Vision Systems (EFVS/SVS).

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of a
meeting of Joint RTCA Special Committee 213: EUROCAE WG-79: Enhanced
Flight

Vision Systems/Synthetic Vision Systems (EFVS/SVS).

DATES: The meeting will be held July 27-29, 2010 from 8:30 a.m.-5 p.m.
(0830-1700).

ADDRESSES: The meeting will be held at the Cedar Rapids Marriott Hotel
1200 Collins Road Northeast, Cedar Rapids, Iowa 52402, Phone: (319)
393-6600. Objectives: Plenary approval DO-315A (MASPS for EFVS approach
and landing). Preparation of draft DO-315B for Final Review and Comment
(FRAC).

FOR FURTHER INFORMATION CONTACT: (1) RTCA Secretariat, 1828 L Street,
NW., Suite 805, Washington, DC, 20036; telephone<PHONE_NUMBER>; fax
(202) 833-9434; Web site http://www.rtca.org.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal
Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., Appendix 2), notice
is hereby given for a Joint RTCA Special Committee 213: EUROCAE WG-79:
Enhanced Flight Vision Systems/Synthetic Vision Systems (EFVS/SVS)
meeting. The agenda will include:

Tuesday, 27 July

     Plenary discussion (sign-in at 0830).
     Introductions and administrative items.
     Review and approve minutes from last full plenary meeting.
     Approve DO-315A final version.
     Review DO-315B performance objectives.

Wednesday, 28 July

     Work Group 1 (SVS) and 2 (EFVS) Discussion (0830-1700,
including breaks and lunch).

Thursday, 29 July

     Plenary discussion (0830-1500, including breaks and
lunch).
     Approve DO-315B draft for FRAC release.
     Administrative items (meeting schedule).
    Attendance is open to the interested public but limited to space
availability. With the approval of the chairmen, members of the public
may present oral statements at the meeting. Persons wishing to present
statements or obtain information should contact the person listed in
the FOR FURTHER INFORMATION CONTACT section. Members of the public may
present a written statement to the committee at any time.

    Issued in Washington, DC, on June 28, 2010.
Francisco Estrada C.,
RTCA Advisory Committee.
[FR Doc. 2010-16258 Filed 7-2-10; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 78, Number 94 (Wednesday, May 15, 2013)]
[Notices]
[Page 28583]
[FR Doc No: 2013-11544]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. AD12-12-000]

 Coordination Between Natural Gas and Electricity Markets; Notice
of Commission Meeting

    Take notice that, pursuant to the Commission order issued on
November 15, 2012,\1\ a representative from each regional transmission
organization (RTO) and independent system operator (ISO) will appear
before the Federal Energy Regulatory Commission (Commission) on May 16,
2013, from 1:30 p.m. (EST) to 3:30 p.m. (EST), to share information
related to natural gas and electric coordination. The meeting will be
held at the Federal Energy Regulatory Commission, 888 First Street NE.,
Washington, DC 20426. All interested persons are invited to attend the
meeting, and no advance registration is necessary. Commission members
will be present.
---------------------------------------------------------------------------

    \1\ Coordination between Natural Gas and Electricity Markets,
141 FERC ] 61,125, at P 11 (2012) (November 15 Order).
---------------------------------------------------------------------------

    Following a series of regional technical conferences conducted in
August 2012, the Commission issued an order directing further
conferences and reports in the above captioned docket on November 15,
2012. In the November 15 Order, the Commission directed each RTO and
ISO to appear before the Commission on May 16, 2013 to share its
experiences from the winter and spring and describe the progress it has
made in refining existing practices to provide better coordination
between the natural gas and electric industries and ensure adequate
fuel supplies. The Commission also directed RTOs and ISOs to address
any natural gas transportation concerns that emerged during the winter
heating season and identify any fuel-related generator outages during
the winter and spring.
    This meeting will not be transcribed. However, there will be a free
webcast of the meeting. The webcast will allow persons to listen to the
meeting, but not participate. Anyone with Internet access who wants to
listen to the meeting can do so by navigating to www.ferc.gov's
Calendar of Events and locating the meeting in the Calendar. The
meeting will contain a link to its webcast. The Capitol Connection
provides technical support for the webcast and offers the option of
listening to the meeting via phone-bridge for a fee. If you have any
questions, visit www.CapitolConnection.org or call<PHONE_NUMBER>.\2\
---------------------------------------------------------------------------

    \2\ The webcast will continue to be available on the Calendar of
Events on the Commission's Web site www.ferc.gov for three months
after the meeting.
---------------------------------------------------------------------------

    Information on the meeting will also be posted on the Web site
http://www.ferc.gov/industries/electric/indus-act/electric-coord.asp,
as well as the Calendar of Events on the Commission's Web site, http://www.ferc.gov, prior to the meeting.
    Commission meetings are accessible under section 508 of the
Rehabilitation Act of 1973. For accessibility accommodations, please
send an email to<EMAIL_ADDRESS>or call toll free (866) 208-
3372 (voice) or<PHONE_NUMBER> (TTY), or send a FAX to<PHONE_NUMBER>
with the required accommodations.
    For more information about the meeting, please contact:
    Caroline Daly (Technical Information), Office of Energy Policy and
Innovation, Federal Energy Regulatory Commission, 888 First Street NE.,
Washington, DC 20426,<PHONE_NUMBER><EMAIL_ADDRESS>    Sarah McKinley (Logistical Information), Office of External
Affairs, Federal Energy Regulatory Commission, 888 First Street NE.,
Washington, DC 20426,<PHONE_NUMBER><EMAIL_ADDRESS>
    Dated: May 9, 2013.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2013-11544 Filed 5-14-13; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 226 (Friday, November 22, 2019)]
[Proposed Rules]
[Pages 64443-64445]
[FR Doc No: 2019-25205]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2019-0873; Product Identifier 2019-NM-164-AD]
RIN 2120-AA64

Airworthiness Directives; Airbus SAS Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: The FAA proposes to adopt a new airworthiness directive (AD)
for certain Airbus SAS Model A319-112, -115, and -132 airplanes; and
Model A320-214, -216, -232, and -233 airplanes. This proposed AD was
prompted by a report that a possible interference was identified
between 1M and 2M wiring harnesses and the tapping units, and that the
interference could adversely affect the lavatory smoke detection system
and/or the passenger oxygen system. This proposed AD would require
modifying the 1M and 2M harness routing, as specified in a European
Union Aviation Safety Agency (EASA) AD, which will be incorporated by
reference. The FAA is proposing this AD to address the unsafe condition
on these products.

DATES: The FAA must receive comments on this proposed AD by January 6,
2020.

ADDRESSES: You may send comments, using the procedures found in 14 CFR
11.43 and 11.45, by any of the following methods:
     Federal eRulemaking Portal: Go to https://www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE, Washington, DC 20590.
     Hand Delivery: Deliver to Mail address above between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
    For the material identified in this proposed AD that will be
incorporated by reference (IBR), contact the EASA, Konrad-Adenauer-Ufer
3, 50668 Cologne, Germany; telephone +49 221 89990 1000; email
<EMAIL_ADDRESS>internet www.easa.europa.eu. You may find this IBR
material on the EASA website at https://ad.easa.europa.eu. You may view
this IBR material at the FAA, Transport Standards Branch, 2200 South
216th St., Des Moines, WA. For information on the availability of this
material at the FAA, call<PHONE_NUMBER>. It is also available in the AD
docket on the internet at https://www.regulations.gov by searching for
and locating Docket No. FAA-2019-0873.

Examining the AD Docket

    You may examine the AD docket on the internet at https://www.regulations.gov by searching for and locating Docket No. FAA-2019-
0873; or in person at Docket Operations between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays. The AD docket contains
this NPRM, the regulatory evaluation, any comments received, and other
information. The street address for Docket Operations is listed above.
Comments will be available in the AD docket shortly after receipt.

FOR FURTHER INFORMATION CONTACT: Sanjay Ralhan, Aerospace Engineer,
International Section, Transport Standards Branch, FAA, 2200 South
216th St., Des Moines, WA 98198; telephone and fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    The FAA invites you to send any written relevant data, views, or
arguments about this proposal. Send your comments to an address listed
under the ADDRESSES section. Include ``Docket No. FAA-2019-0873;
Product Identifier 2019-NM-164-AD'' at the beginning of your comments.
The FAA specifically invites comments on the overall regulatory,
economic, environmental, and energy aspects of this NPRM. The FAA will
consider all comments received by the closing date and may amend this
NPRM based on those comments.
    The FAA will post all comments, without change, to https://www.regulations.gov, including any personal information you provide.
The FAA will also post a report summarizing each substantive verbal
contact the agency receives about this NPRM.

Discussion

    The EASA, which is the Technical Agent for the Member States of the
European Union, has issued EASA AD 2019-0227, dated September 11, 2019
(``EASA AD 2019-0227'') (also referred to as the Mandatory Continuing
Airworthiness Information, or ``the MCAI''), to correct an unsafe
condition for certain Airbus SAS Model A319-112, -115, and -132
airplanes; and Model A320-214, -216, -232 and -233 airplanes.
    This proposed AD was prompted by a report that a possible
interference was identified between 1M and 2M wiring harnesses and the
tapping units. It was determined that the root cause for this
interference was caused by a modified optional tapping unit design,
reducing the clearance between the wire harnesses and the tapping unit.
Further investigation determined that interference could adversely
affect the lavatory smoke detection system and/or the passenger oxygen
system. The FAA is proposing this AD to address possible loss of
lavatory smoke detection and/or loss of passenger oxygen system
commands, which could prevent the delivery of passenger oxygen during
an emergency, and possibly result in injury to airplane occupants. See
the MCAI for additional background information.

Related IBR Material Under 1 CFR Part 51

    EASA AD 2019-0227 describes procedures for modifying the 1M and 2M
harness routing. This material is reasonably available because the
interested parties have access to it through their normal course of
business or by the means identified in the ADDRESSES section.

FAA's Determination and Requirements of This Proposed AD

    This product has been approved by the aviation authority of another
country, and is approved for operation in the United States. Pursuant
to the FAA's bilateral agreement with the State of Design Authority,
the FAA has been notified of the unsafe condition described in the MCAI
referenced above. The FAA is proposing this AD because the FAA
evaluated all the relevant information and determined the unsafe
condition described previously is likely to exist or develop in other
products of the same type design.

Proposed AD Requirements

    This proposed AD would require accomplishing the actions specified
in EASA AD 2019-0227 described previously, as incorporated by
reference, except for any differences identified as exceptions in the
regulatory text of this AD.

Explanation of Required Compliance Information

    In the FAA's ongoing efforts to improve the efficiency of the AD
process, the FAA initially worked with Airbus and EASA to develop a
process to use certain EASA ADs as the primary source of information
for compliance with requirements for corresponding FAA ADs. The FAA has
since coordinated with other manufacturers and civil aviation
authorities (CAAs) to use this process. As a result, EASA AD 2019-0227
will be incorporated by reference in the FAA final rule. This proposed
AD would, therefore, require compliance with EASA AD 2019-0227 in its
entirety, through that incorporation, except for any differences
identified as exceptions in the regulatory text of this proposed AD.
Using common terms that are the same as the heading of a particular
section in the EASA AD does not mean that operators need comply only
with that section. For example, where the AD requirement refers to
``all required actions and compliance times,'' compliance with this AD
requirement is not limited to the section titled ``Required Action(s)
and Compliance Time(s)'' in the EASA AD. Service information specified
in EASA AD 2019-0227 that is required for compliance with EASA AD 2019-
0227 will be available on the internet at http://www.regulations.gov by
searching for and locating Docket No. FAA-2019-0873 after the FAA final
rule is published.

Costs of Compliance

    The FAA estimates that this proposed AD affects 6 airplanes of U.S.
registry. The FAA estimates the following costs to comply with this
proposed AD:

                                      Estimated Costs for Required Actions
----------------------------------------------------------------------------------------------------------------
                                                                                Cost per        Cost on U.S.
                        Labor cost                             Parts cost        product           operators
----------------------------------------------------------------------------------------------------------------
6 work-hours x $85 per hour = $510........................            $180             $690              $4,140
----------------------------------------------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    The FAA is issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: ``General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.
    This proposed AD is issued in accordance with authority delegated
by the Executive Director, Aircraft Certification Service, as
authorized by FAA Order 8000.51C. In accordance with that order,
issuance of ADs is normally a function of the Compliance and
Airworthiness Division, but during this transition period, the
Executive Director has delegated the authority to issue ADs applicable
to transport category airplanes and associated appliances to the
Director of the System Oversight Division.

Regulatory Findings

    The FAA determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Will not affect intrastate aviation in Alaska, and
    (3) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities

under the criteria of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive (AD):

Airbus SAS: Docket No. FAA-2019-0873; Product Identifier 2019-NM-
164-AD.

(a) Comments Due Date

    The FAA must receive comments by January 6, 2020.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to Airbus SAS Model A319-112, -115, and -132
airplanes; and Model A320-214, -216, -232 and -233 airplanes;
certificated in any category; as identified in European Union
Aviation Safety Agency (EASA) AD 2019-0227, dated September 11, 2019
(``EASA AD 2019-0227'').

(d) Subject

    Air Transport Association (ATA) of America Code 92, Electric and
Electronic
    Common Installation.

(e) Reason

    This AD was prompted by a report that a possible interference
was identified between 1M and 2M wiring harnesses and the tapping
units, and that the interference could adversely affect the lavatory
smoke detection system and/or the passenger oxygen system. The FAA
is issuing this AD to address possible loss of lavatory smoke
detection and/or passenger oxygen system commands, which could
prevent the delivery of passenger oxygen during an emergency and
possibly result in injury to airplane occupants.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Requirements

    Except as specified in paragraph (h) of this AD: Comply with all
required actions and compliance times specified in, and in
accordance with, EASA AD 2019-0227.

(h) Exceptions to EASA AD 2019-0227

    (1) Where EASA AD 2019-0227 refers to its effective date, this
AD requires using the effective date of this AD.
    (2) The ``Remarks'' section of EASA AD 2019-0227 does not apply
to this AD.

(i) Other FAA AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
International Section, Transport Standards Branch, FAA, has the
authority to approve AMOCs for this AD, if requested using the
procedures found in 14 CFR 39.19. In accordance with 14 CFR 39.19,
send your request to your principal inspector or local Flight
Standards District Office, as appropriate. If sending information
directly to the International Section, send it to the attention of
the person identified in paragraph (j)(2) of this AD. Information
may be emailed to<EMAIL_ADDRESS>Before using any
approved AMOC, notify your appropriate principal inspector, or
lacking a principal inspector, the manager of the local flight
standards district office/certificate holding district office.
    (2) Contacting the Manufacturer: For any requirement in this AD
to obtain instructions from a manufacturer, the instructions must be
accomplished using a method approved by the Manager, International
Section, Transport Standards Branch, FAA; or EASA; or Airbus SAS's
EASA Design Organization Approval (DOA). If approved by the DOA, the
approval must include the DOA-authorized signature.
    (3) Required for Compliance (RC): For any service information
referenced in EASA AD 2019-0227 that contains RC procedures and
tests: Except as required by paragraph (i)(2) of this AD, RC
procedures and tests must be done to comply with this AD; any
procedures or tests that are not identified as RC are recommended.
Those procedures and tests that are not identified as RC may be
deviated from using accepted methods in accordance with the
operator's maintenance or inspection program without obtaining
approval of an AMOC, provided the procedures and tests identified as
RC can be done and the airplane can be put back in an airworthy
condition. Any substitutions or changes to procedures or tests
identified as RC require approval of an AMOC.

(j) Related Information

    (1) For information about EASA AD 2019-0227, contact the EASA,
Konrad-Adenauer-Ufer 3, 50668 Cologne, Germany; telephone +49 221
89990 6017; email<EMAIL_ADDRESS>Internet www.easa.europa.eu.
You may find this EASA AD on the EASA website at https://ad.easa.europa.eu. You may view this material at the FAA, Transport
Standards Branch, 2200 South 216th St., Des Moines, WA. For
information on the availability of this material at the FAA, call
206-231-3195. This material may be found in the AD docket on the
internet at https://www.regulations.gov by searching for and
locating Docket No. FAA-2019-0873.
    (2) For more information about this AD, contact Sanjay Ralhan,
Aerospace Engineer, International Section, Transport Standards
Branch, FAA, 2200 South 216th St., Des Moines, WA 98198; telephone
and fax<PHONE_NUMBER>.

    Issued in Des Moines, Washington, on November 15, 2019.
Dionne Palermo,
Acting Director, System Oversight Division, Aircraft Certification
Service.
[FR Doc. 2019-25205 Filed 11-21-19; 8:45 am]
 BILLING CODE 4910-13-P


[Federal Register Volume 77, Number 127 (Monday, July 2, 2012)]
[Notices]
[Page 39321]
[FR Doc No: 2012-16110]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Eighth Meeting: RTCA Special Committee 225, Rechargeable Lithium
Battery and Battery Systems--Small and Medium Sizes

AGENCY: Federal Aviation Administration (FAA), U.S. Department of
Transportation (DOT).

ACTION: Meeting Notice of RTCA Special Committee 225, Rechargeable
Lithium Battery and Battery Systems--Small and Medium Sizes.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of the
eighth meeting of RTCA Special Committee 225, Rechargeable Lithium
Battery and Battery Systems--Small and Medium Sizes.

DATES: The meeting will be held July 17-19, 2012, from 9 a.m.-5 p.m.

ADDRESSES: The meeting will be held at RTCA, Inc., 1150 18th Street
NW., Suite 910, Washington, DC, 20036.

FOR FURTHER INFORMATION CONTACT: The RTCA Secretariat, 1150 18th Street
NW., Suite 910, Washington, DC, 20036, or by telephone at (202) 833-
9339, fax at<PHONE_NUMBER>, or Web site at http://www.rtca.org.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a) (2) of the Federal
Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., App.), notice is
hereby given for a meeting of Special Committee 225. The agenda will
include the following:

Tuesday, July 17, 2012

     Introductions and administrative items.
     Review and approve agenda
     Review and approval of summary from last plenary meeting.
     Update to TOR.
     Review schedule for upcoming Plenaries, working group
meetings, and document preparation.
     Review action items.
     Working Group Meeting--Review draft document.

Wednesday, July 18

     Review agenda, other actions.
     Working Group Meeting--Review draft document.

Thursday, July 19

     Review agenda, other actions.
     Verify dates of next plenary and upcoming working group
meetings.
     Establish Agenda for next plenary meeting.
     Working Group Meeting--Review draft document.
     Working Group report, review progress and actions.
     Review new action items.
     Adjourn.
    Attendance is open to the interested public but limited to space
availability. With the approval of the chairman, members of the public
may present oral statements at the meeting. Persons wishing to present
statements or obtain information should contact the person listed in
the FOR FURTHER INFORMATION CONTACT section. Members of the public may
present a written statement to the committee at any time.

    Issued in Washington, DC, on June 26, 2012.
David Sicard,
Manager, Business Operations Branch, Federal Aviation Administration.
[FR Doc. 2012-16110 Filed 6-29-12; 8:45 am]
BILLING CODE 4910-13-P


Australia and New Zealand  -  The Food Standards Australia New Zealand (FSANZ), a statutory authority in the Australian Government health portfolio, and the National Medical Research Council have developed health-based guidance values for PFOA, PFOS, and PFHxS for exposure from food, drinking water and surface water used for recreation. The guidance values give tolerable daily intake (TDI) for lifetime exposure levels from food or drinking water that will not result in significant risk to human health. Based on the TDI, FSANZ recommended tolerable daily intake and issued drinking water and recreational water guideline values for use in site investigations in Australia. TDI were derived from animal studies and pharmacokinetic modeling used to extrapolate to humans. For PFHxS, FSANZ concluded that the available data were insufficient to develop a TDI and that the PFOS TDI should be applied to PFHxS and a combined concentration of PFOS plus PFHxS should be used to evaluate exposure.
                          Health based guidance value
                               Total PFOS+PFHxS
                                     PFOA
                            Tolerable daily intake
                  (nanograms/kilogram of body weight per day)
                                      20
                                      160
                    Drinking water quality guideline value
                             (nanograms per liter)
                                      70
                                      560
                  Recreational water quality guideline value
                             (nanograms per liter)
                                     2,000
                                    10,000

      Canada - PFOA, its salts and precursors, as well as long-chain perfluorocarboxylic acids, their salts and precursors were assessed in 2012. These substances are prohibited for import and use with a limited number of exemptions under the Prohibition of Certain Toxic Substances Regulations, 2012. In 2018 additional proposed amendments to the Canadian Environmental Protection Act, 1999, to regulate additional PFAS were postponed to late 2021. The proposed amendments include PFOS, its salts and precursors that contain one of the following groups: C8F17SO2, C8F17SO3 or C8F17SO2N (PFOS), PFOA and its salts and precursors. It also includes all longer chain perfluorocarboxylic acids having the molecular formula CnF2n+1CO2H in which 8 <= n <= 20, their salts and precursors.[,]
      Guidelines for Canadian Drinking Water Quality set the maximum acceptable concentration (MAC) for PFOA in drinking water at 200 ppt and PFOS in drinking water at 600 ppt. These MACs are based on exposure to individual chemicals. Because the toxicological effects of PFOA and PFOS are additive they should be evaluated together, and the ratio of the observed concentration for PFOS to its MAC plus the ratio of the observed concentration for PFOA to its MAC should be below 1 for drinking water to considered safe.[,] For other PFAS with a more limited database, drinking water screening values were developed.
      Peoples Republic of China - The "Industrial Recon-structuring Guide Directory" restricted the production of PFOS and PFOA. In 2014, the Ministry of Environmental Protection announcement No. [2014]21, banned "production, transportation, application, imports and exports of PFOS, its salts, and POSF, except for specific exemptions and acceptable use."
      Denmark - Based on toxicity the Danish Environmental Protection Agency has identified health-based criteria or limit values for drinking water, groundwater used for drinking water and soil. Criteria or limit values for drinking water and groundwater used for drinking water are 100 nanograms per liter for PFOS and/or PFOSA (a PFOS precursor) and 300 nanograms per liter for PFOA. For cumulative exposure the ratio of the sum of concentration/limit value ratios for PFOA, PFOS and PFOSA should be below 1.
      The health-based criteria or limit value for soil is 390 micrograms per kilogram for PFOS and PFOSA and 1,300 micrograms per kilogram for PFOA and its salts. Cumulatively the sum of concentration/limit value ratios for PFOA, PFOS and PFOSA should be below 1.
      The Danish Ministry of the Environment and Food banned food contact paper and cardboard in which per and polyfluoro chemicals, including PFOA and PFOS and their salts and precursors, have been used unless they incorporate a barrier to prevent migration into food.
      Japan - In 2010, Japan designated PFOS, its salts, and POSF as Class I Specified Chemical Substances following their addition to the Stockholm Convention on Persistent to Organic Pollutants Annex B regulating manufacture, use, export, and import of PFOA and its salts.
      Norway - Norway listed PFOA and PFOS on its national list of priority substances based on monitoring data that showed high levels of these substances in the environment as well as their toxicological profiles. In 2014, Norway banned manufacturing, production, import and retail of consumer products containing PFOA.
VIII.	Statutory and Executive Order Reviews
      Additional information about these statutes and Executive Orders can be found at https://www.epa.gov/laws-regulations/laws-and-executive-orders.
A.	Executive Order 12866: Regulatory Planning and Review and Executive Order 13563: Improving Regulation and Regulatory Review
      This action is a significant regulatory action that was submitted to the OMB for review. While EPA is not considering costs in its hazardous substance designation decisions in this proposed rule, and despite that there is still significant uncertainty and lack of data as discussed in the economic analysis (EA), OMB designated this proposed rulemaking as an economically significant action.  Any changes made in response to the OMB recommendations have been documented in the docket. Although CERCLA section 102(a) precludes EPA from taking cost into account in the designation of a hazardous substance, to inform the public, EPA prepared an EA of the potential costs, benefits, and impacts associated with this action. This analysis, Economic Assessment of the Potential Costs and Other Impacts of the Proposed Rulemaking to Designate Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid as Hazardous Substances is available in the docket for this action. The EA includes request for comments on several topics that EPA does not currently have robust information about. Please see Section ES-5 of the EA for specific details.
      If finalized, this proposed CERCLA designation is estimated to have a quantifiable direct annual social cost of approximately $370,000 from reporting releases at or above the RQ. Additional, unquantifiable future costs may occur when Federal agencies sell or transfer real property where PFOA or PFOS was stored, released or disposed of as specified by CERCLA section 120(h).  There is also the direct effect resulting in an obligation of DOT to list and regulate CERCLA-designated hazardous substances as hazardous materials under the Hazardous Materials Transportation Act (see CERCLA Section 306(a)). EPA estimates these incremental costs associated with the DOT rulemaking as zero or negligible. This action's direct benefits from release reporting include improved quality of information providing a more comprehensive understanding of the number and location of PFOA and PFOS releases meeting or exceeding the RQ. An important benefit of this information is that it may lead to more efficient property and capital markets. Another potential direct benefit from the proposed reporting requirement is better waste management and/or treatment by facilities handling PFOA or PFOS. Greater transparency provided by release reporting can lead to fewer releases to the environment and thus to health benefits associated with avoided exposure.
       Designating PFOA and PFOS as hazardous substances may also have indirect, indeterminate impacts associated with potential increases in the speed of response activity and in the total number of response actions taken to address PFOA and PFOS releases. Both potential increases may lead to health benefits associated with avoided risks. Other indirect effects may be experienced as a result of the movement forward in time of assessment and cleanup costs.  The proposed designation would also improve the Agency's ability to transfer response costs from the public to polluters contingent upon specific statutory requirements being met and discretionary actions by EPA. These indirect costs, benefits, and transfers cannot be quantified due to significant uncertainties about each. The full discussion of these impacts can be found in the EA.
B.	Paperwork Reduction Act
      The information collection activities in this proposed rule have been submitted for approval to the OMB under the Paperwork Reduction Act. The Information Collection Request (ICR) document that the EPA prepared has been assigned EPA ICR number 2708.01. You can find a copy of the ICR in the docket for this rule, and it is briefly summarized here.
      If finalized, the designation of PFOA and PFOS, and their salts and structural isomers, as hazardous substances would require any person in charge of a vessel or facility that identifies a release of one pound or more within a 24-hour period of these substances to report the release to the NRC under section 103 of CERCLA and to the SERC (or TERC) and LEPC (or TEPC) under section 304 of EPCRA. The implementing regulations of CERCLA section 103 and EPCRA section 304 are codified at 40 CFR parts 302 and 355, respectively.
Respondents/affected entities: Any person in charge of a vessel or facility from which there is a release of PFOA or PFOS and their salts and structural isomers, equal to or greater than the RQ of one pound within 24 hours.
Respondent's obligation to respond: Mandatory under section 103 of CERCLA and section 304 of EPCRA.
Estimated number of respondents: From 0 to 660 releases per year.
Frequency of response: Varies.
Total estimated burden: 6,415 hours (per year) maximum. Burden is defined at 5 CFR 1320.3(b).
Total estimated cost: $370,000 (per year) maximum, includes $3,503 annualized operation and maintenance costs (and no capital costs).
      An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control numbers for the EPA's regulations in 40 CFR are listed in 40 CFR 9.
      Submit your comments on the Agency's need for this information, the accuracy of the provided burden estimates and any suggested methods for minimizing respondent burden to the EPA using the docket identified at the beginning of this rule. You may also send your ICR-related comments to OMB's Office of Information and Regulatory Affairs using the interface at www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting "Currently under Review -- Open for Public Comments" or by using the search function. Since OMB is required to make a decision concerning the ICR between 30 and 60 days after receipt, OMB must receive comments no later than [INSERT DATE 30 DAYS AFTER PUBLICATION IN THE FEDERAL REGISTER]. The EPA will respond to any ICR-related comments in the final rule.
C.	Regulatory Flexibility Act (RFA)
      I certify that this action will not have a significant economic impact on a substantial number of small entities under the RFA. The small entities subject to the requirements of this action are: (1) producers and importers of PFOA and PFOS, (2) producers and users of PFOA or PFOS-containing articles, and (3) waste management and wastewater facilities. The Agency has estimated that there may be up to 660 reported releases of PFOA or PFOS in any one year and that an indeterminate number, but small percentage, of the annual reports will be submitted by small entities.  The estimated cost of $561 to report a release of PFOA or PFOS is not greater than 1% of the annual revenues per small entity in any impacted industry. Details of this analysis are presented in the Economic Assessment of the Potential Costs and Other Impacts of the Proposed Rulemaking to Designate Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid as Hazardous Substances. We have therefore concluded that this action will not have a significant regulatory burden for all directly regulated small entities.
D.	Unfunded Mandates Reform Act (UMRA)
      This action does not contain an unfunded mandate of $100 million or more as described in UMRA, 2 U.S.C. 1531 - 1538, and does not significantly or uniquely affect small governments. This action is expected to result in reporting costs of $561 per release that meets or exceeds the RQ, and the estimated annual cost of the proposed rule is not expected to exceed $370,000 per year.
E.	Executive Order 13132: Federalism
      This action does not have federalism implications. It will not have substantial direct effects on the states, on the relationship between the national government and the states, or on the distribution of power and responsibilities among the various levels of government.
F.	Executive Order 13175: Consultation and Coordination with Indian Tribal Governments
      This action does not have Tribal implications as specified in Executive Order 13175 because it does not have substantial direct effects on one or more Tribal Nations, on the relationship between the Federal Government and Tribal Nations, or on the distribution of power and responsibilities between the Federal Government and Tribal Nations. EPA does not expect that it would result in any adverse impacts on tribal entities. Thus, Executive Order 13175 does not apply to this action.
      Consistent with the EPA Policy on Consultation with Tribal Nations, the EPA intends to consult with and request comments from tribal officials.
G.	Executive Order 13045: Protection of Children from Environmental Health Risks and Safety Risks
      This action, which proposes to designate PFOA and PFOS as hazardous substances, does not itself address environmental health or safety risks. Beyond the requirements of EO 13045, EPA's 2021 Policy on Children's Health (October 5, 2021) requires EPA to consider early life exposures and lifelong health consistently and explicitly in all human health decisions. The EPA believes that the environmental health or safety risk posed by exposure to PFOA and/or PFOS may have a disproportionate effect on children. A discussion of health and risk assessments related to PFOA and PFOS, including developmental and reproductive health effects, are contained in EPA's Health Effects Support Documents for PFOA and PFOS (2016).
H.	Executive Order 13211: Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution or Use
      This action is not a "significant energy action" because it is not likely to have a significant adverse effect on the supply, distribution or use of energy. This action proposes to designate PFOA and PFOS as hazardous substances, and thus, does not involve the supply, distribution or use of energy.
I.	National Technology Transfer and Advancement Act
      This action does not involve technical standards.
J.	Executive Order 12898: Federal Actions to Address Environmental Justice in Minority Populations and Low-Income Populations
      The EPA is unable to determine if this action does or does not have disproportionately high and adverse human health or environmental effects on minority populations, low-income populations and/or indigenous peoples, as specified in Executive Order 12898 (59 FR 7629, February 16, 1994).
      Several key demographic categories were analyzed relative to facilities with known historical use and/or releases of PFOA and PFOS. Because the location of future releases of PFAS is uncertain, this analysis considers populations around facilities in sectors associated with widespread historical uses and releases of PFAS as proxies for facilities that may have future releases of the PFAS considered in the proposed rule. This analysis examines the following site types as proxies for facilities that are known to have commonly used PFAS:
             Operating Department of Defense (DOD) facilities
             Operating U.S. airports and airfields
             Plastics material and resin manufacturing firms identified as having produced PFOS and/or PFOA,
             2020 PFOS and PFOA releases reported to EPA's Toxic Release Inventory (TRI)
      On average, airports across the U.S. are surrounded by populations that reflect national averages in relevant demographic categories. Large airports, however, are more likely to be surrounded by minority and low-income populations than medium or small airports. Some DOD sites are surrounded by populations with higher concentrations of minority and low-income residents, but the majority of these sites are below the national averages for these metrics. In contrast, areas around plastics material and resin manufacturer sites and/or sites reporting releases to TRI, on average, are in areas with higher concentrations of minority residents and households experiencing poverty than the U.S. averages for these demographics, suggesting that releases related to manufacturing facilities could have environmental justice implications.  A complete discussion of the analysis behind these findings is available in Section 4.3 of the EA accompanying this rulemaking. These findings, combined with the uncertainty surrounding the location of future releases, are indicative of potential impacts but do not provide a clear indication of the type of disparities related to potential exposure to PFAS. Consistent with the priorities outlined in Executive Orders 12898 and 14008, it is unclear whether this proposed regulation will have a significant impact on disadvantaged populations or communities with environmental justice (EJ) concerns relative to other communities. While the locations that may report releases are unknown, to the extent that these proxy locations are representative of likely reporting locations, this screening analysis suggests that the reporting required under the rule may provide better information to nearby populations potentially at risk of exposure, including communities with EJ concerns. To the extent that PFAS releases are consistent with the broader releases reported to TRI and typically involve disposal or manufacturing sites, demographic data around plastics material and resin manufacturer sites and historical releases may be a more reliable predictor of the type of community potentially affected by this proposed rulemaking.  Specific site conditions and demographic patterns may become clear as reporting occurs following completion of a final rule. Once available, this information would improve EPA's ability to examine disparate impacts on EJ communities. This improved information would not increase risk for communities with EJ concerns and may improve the speed and design of remediation.  EPA is committed to minimizing and/or eliminating existing barriers and burdens that communities with EJ concerns may encounter related to accessing data and information collected as a result of this rulemaking, if finalized. EPA seeks comment on strategies to improve access to the reporting data expected to be collected, if designation of PFOA and PFOS as hazardous substances is finalized, for communities with environmental justice concerns.
      Further, the documentation for this decision is contained in the following sections in the preamble to this action: II.C., VI.A. and B. These sections explain that the designation of PFOA and PFOS as hazardous substances, if finalized, and the required reporting and notification requirements, will result in more information about the location and extent of releases. This improved information does not increase risk or result in any adverse environmental justice impacts.
List of Subjects in 40 CFR Part 302
      Environmental protection, Air pollution control, Chemicals, Hazardous substances, Hazardous waste, Intergovernmental relations, Natural resources, Reporting and recordkeeping requirements, Superfund, Water pollution control, Water supply.

Dated

Michael S. Regan,
Administrator.
      For the reasons set forth in the preamble, EPA proposes to amend 40 CFR part 302 as follows:
PART 302  - DESIGNATION, REPORTABLE QUANTITIES, AND NOTIFICATION:
1. The authority citation for part 302 continues to read as follows:
      Authority: 33 U.S.C. 1251 et. seq., 42 U.S.C. 9601, 42 U.S.C. 9602, 42 U.S.C. 9603
§ 302.4 [Amended]
2. In § 302.4:
a. Note II to Table 302.4 is revised to read as follows:
* * * * *
Note II to Table 302.4
Hazardous substances are given a Statutory Code based on their statutory source. The "Statutory Code" column indicates the statutory source for designating each substance as a CERCLA hazardous substance. Statutory Code "1" indicates a Clean Water Act (CWA) Hazardous Substance. Statutory Code "2" indicates a CWA Toxic Pollutant. Statutory Code "3" indicates a CAA HAP. Statutory Code "4" indicates Resource Conservation and Recovery Act (RCRA) Hazardous Wastes. Statutory Code "5" indicates a hazardous substance designated under section 102(a) of CERCLA. The "RCRA waste No." column provides the waste identification numbers assigned by RCRA regulations. The "Final RQ [pounds (kg)]" column provides the reportable quantity for each hazardous substance in pounds and kilograms.
b. Table 302.4 -- List of Hazardous Substances and Reportable Quantities is amended by listing in alphabetical order the following new entries:
       Table 302.4 -- List of Hazardous Substances and Reportable Quantities
             [All Comments/Notes Are Located at the End of This Table]

                                Hazardous Substance
                                      ******
                                      CASRN

                                Statutory
code †

                                  RCRA
waste
No.
                              Final RQ
[pounds (Kg)]
        Perfluorooctanesulfonic acid, & salts, & structural isomers
                                     1763-23-1
                                         5

                                    ## (0.454)
           Perfluorooctanoic acid, & salts, & structural isomers
                                     335-67-1
                                         5

                                    ## (0.454)
* * * * * * *

c.	Appendix A to § 302.4 -- Sequential CAS Registry Number List of CERCLA Hazardous Substances is amended by adding the following new entries in alphabetical order:
    Appendix A to §302.4  -- Sequential CAS Registry Number List of CERCLA Hazardous Substances:

                                     CASRN
                              Hazardous Substance
335-67-1
Perfluorooctanoic acid, & salts, & structural isomers
1763-23-1
Perfluorooctanesulfonic acid, & salts, & structural isomers


[Federal Register Volume 80, Number 100 (Tuesday, May 26, 2015)]
[Notices]
[Page 30072]
[FR Doc No: 2015-12607]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No., 5766-008]

TKO Power, Inc., TKO Power, LLC; Notice of Transfer of Exemption

    1. By letter filed April 24, 2015,\1\ William B. Conway, Jr.,
Counsel for Enel Green Power North America, Inc. (EGPNA),\2\ informed
the Commission that the exemption from licensing for the Nichols
Project, FERC No. 5766, originally issued April 22, 1982,\3\ has been
transferred to TKO Power, LLC, an affiliate of Enel Green Power. The
project is located on South Fork Bear Creek in Shasta County,
California. The transfer of an exemption does not require Commission
approval.
---------------------------------------------------------------------------

    \1\ Seventeen other exempted projects which are to be
transferred were included in the April 24, 2015 letter. These
exemptions will be handled under separate proceedings.
    \2\ Enel Green Power North America, Inc. is a wholly owned
subsidiary of Enel Green Power. Enel Green Power is a well-
capitalized publicly traded company.
    \3\ 19 FERC ] 62,111, Order Granting Exemption from Licensing of
a Small Hydroelectric Project of 5 MW or Less (1982).
---------------------------------------------------------------------------

    2. TKO Power, LLC is now the exemptee of the Nichols Project, FERC
No. 5766. All correspondence should be forwarded to: TKO Power, LLC, c/
o Enel Green Power North America, Inc., Attn: General Counsel, 1 Tech
Drive, Suite 220, Andover, MA 01810.

    Dated: May 19, 2015.
Kimberly D. Bose,
Secretary.
[FR Doc. 2015-12607 Filed 5-22-15; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register Volume 77, Number 16 (Wednesday, January 25, 2012)]
[Notices]
[Pages 3781-3782]
[FR Doc No: 2012-1443]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0754]

Pediatric Medical Devices; Public Workshop; Reopening of Comment
Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; reopening of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is reopening until
March 5, 2012, the comment period for the notice entitled ``Pediatric
Medical Devices; Public Workshop; Request for Comments'' that appeared
in the Federal Register of Tuesday, November 1, 2011 (76 FR 67463). In
the notice, FDA announced a public workshop to consider factors
affecting the use of scientific research data to support pediatric
medical device efficacy claims. This is part of an on-going effort to
address the ways scientific research data can be used to support
pediatric effectiveness claims for medical devices and pediatric device
approvals or clearance; the scientific and regulatory limitations and
issues of using existing scientific research data to support pediatric
effectiveness claims and pediatric indication approvals for medical
devices; and methods to overcome the pitfalls and data gaps, including
statistical approaches and modeling. The agency is taking this action
to allow interested persons additional time to submit comments on the
use of scientific research data, including published scientific
literature, to support and establish pediatric indications for medical
devices.

DATES: Submit either electronic or written comments by March 5, 2012.

ADDRESSES: Submit electronic comments to http://www.regulations.gov.
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Carol Krueger, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5437, Silver Spring, MD 20993-0002,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    In 2007, Congress passed the Pediatric Medical Device Safety and
Improvement

Act (the Act). The Act addresses pediatric device needs by providing
financial incentives for development, production, approval and
distribution of new devices for rare and unmet pediatric needs;
allowing for a pediatric device approval pathway that permits
extrapolation of adult effectiveness data to support a pediatric
indication based on similar course of the disease or condition or a
similar effect of the device; and providing grants to pediatric device
consortia that provide technical support and assistance to pediatric
device innovators.
    FDA held a public workshop on December 5, 2011, to support FDA's
efforts to define pathways for approving pediatric device indications
by leveraging available scientific research data. An important, but not
the only, focus was a discussion of how to determine when it is
appropriate to use, and how to use, existing scientific research data
to determine pediatric effectiveness based on a similar course of a
disease or condition or a similar effect of a device on adults and
similar extrapolation between pediatric subpopulations.
    The demand by health care professionals and consumers for safe and
effective pediatric medical devices continues to steadily increase.
Pediatric medical devices treat or diagnose diseases and conditions
occurring from birth through the 21st year of life. Some devices are
designed specifically for pediatric use, while others are adopted from
specific adult device applications or produced for more general use.
    Designing pediatric medical devices can be challenging; children
are often smaller and more active than adults; body structures and
functions change throughout childhood, and children may be long-term
device users--bringing new concerns about device longevity and long-
term exposure to implanted materials. The current medical device market
for children has a higher demand than supply. FDA is committed to
supporting the development and availability of safe and effective
pediatric medical devices.
    Regardless of attendance at the public workshop, interested persons
may submit either electronic or written comments on the topics
discussed at the Public Workshop.

II. Topics Discussed at the Public Workshop

    The public workshop discussed the following topic areas:
    1. The use of existing scientific research data to support
pediatric effectiveness claims for medical devices and pediatric device
approvals or clearance,
    2. The scientific and regulatory limitations and issues with the
use of existing scientific research data, and
    3. The methods to overcome the pitfalls and data gaps, including
statistical approaches and modeling.

III. Transcripts

    Please be advised that a transcript of the public workshop is
available at http://www.regulations.gov at FDA docket number FDA-2011-
N-0754. The transcript may be viewed at the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852. A transcript is also available online at
http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm278053.htm.

IV. Comments

    Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
document. It is only necessary to send one set of comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: January 19, 2012.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices and Radiological Health.
[FR Doc. 2012-1443 Filed 1-24-12; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register Volume 85, Number 101 (Tuesday, May 26, 2020)]
[Notices]
[Page 31538]
[FR Doc No: 2020-11169]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4501-DR; Docket ID FEMA-2020-0001]

Georgia; Major Disaster and Related Determinations

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice of the Presidential declaration of a major
disaster for the State of Georgia (FEMA-4501-DR), dated March 29, 2020,
and related determinations.

DATES: The declaration was issued March 29, 2020.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Notice is hereby given that, in a letter
dated March 29, 2020, the President issued a major disaster declaration
under the authority of the Robert T. Stafford Disaster Relief and
Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the ``Stafford
Act''), as follows:

    I have determined that the emergency conditions in the State of
Georgia resulting from the Coronavirus Disease 2019 (COVID-19)
pandemic beginning on January 20, 2020, and continuing, are of
sufficient severity and magnitude to warrant a major disaster
declaration under the Robert T. Stafford Disaster Relief and
Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the ``Stafford
Act''). Therefore, I declare that such a major disaster exists in
the State of Georgia.
    In order to provide Federal assistance, you are hereby
authorized to allocate from funds available for these purposes such
amounts as you find necessary for Federal disaster assistance and
administrative expenses.
    You are authorized to provide assistance for emergency
protective measures (Category B), including direct Federal
assistance, under the Public Assistance program throughout the
State. Consistent with the requirement that Federal assistance be
supplemental, any Federal funds provided under the Stafford Act for
Public Assistance will be limited to 75 percent of the total
eligible costs.
    Further, you are authorized to make changes to this declaration
for the approved assistance to the extent allowable under the
Stafford Act.

    The Federal Emergency Management Agency (FEMA) hereby gives notice
that pursuant to the authority vested in the Administrator, under
Executive Order 12148, as amended, Gracia B. Szczech, of FEMA is
appointed to act as the Federal Coordinating Officer for this major
disaster.
    The following areas of the State of Georgia have been designated as
adversely affected by this major disaster:

    Emergency protective measures (Category B) not authorized under
other Federal statutes, including direct Federal assistance, under
the Public Assistance program at 75 percent federal funding for all
areas in the State of Georgia.

The following Catalog of Federal Domestic Assistance Numbers (CFDA)
are to be used for reporting and drawing funds: 97.030, Community
Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034, Disaster Unemployment
Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048,
Disaster Housing Assistance to Individuals and Households In
Presidentially Declared Disaster Areas; 97.049, Presidentially
Declared Disaster Assistance--Disaster Housing Operations for
Individuals and Households; 97.050, Presidentially Declared Disaster
Assistance to Individuals and Households--Other Needs; 97.036,
Disaster Grants--Public Assistance (Presidentially Declared
Disasters); 97.039, Hazard Mitigation Grant.

Pete Gaynor,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2020-11169 Filed 5-22-20; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register Volume 83, Number 183 (Thursday, September 20, 2018)]
[Rules and Regulations]
[Pages 47557-47560]
[FR Doc No: 2018-20375]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 172

[Docket No. FDA-2017-F-3717]

Food Additives Permitted for Direct Addition to Food for Human
Consumption; Vitamin D3

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is amending the
food additive regulation for vitamin D3 to replace the
current Reference Daily Intake (RDI) percentage values of calcium in
100 percent fruit juices and fruit juice drinks with absolute values
and to update the reference for vitamin D3 specifications.
We are taking this action in response to a food additive petition filed
by the Juice Products Association.

DATES: This rule is effective September 20, 2018. Submit either
electronic or written objections and requests for a hearing on the
final rule by October 22, 2018. The Director of the Federal Register
approves the incorporation by reference of certain publications listed
in the rule as of September 20, 2018. See the ADDRESSES section and the
OBJECTIONS section IX of this document for further information on
filing objections.

ADDRESSES: You may submit objections and requests for a hearing as
follows. Please note that late, untimely filed objections will not be
considered. Electronic objections must be submitted on or before
October 22, 2018. The https://www.regulations.gov electronic filing
system will accept objections until midnight Eastern Time at the end of
October 22, 2018. Objections received by mail/hand delivery/courier
(for written/paper submissions) will be considered timely if they are
postmarked or the delivery service acceptance receipt is on or before
that date.

Electronic Submissions

    Submit electronic objections in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Objections submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your objection will be
made public, you are solely responsible for ensuring that your
objection does not include any confidential information that you or a
third party may not wish to be posted, such as medical information,
your or anyone else's Social Security number, or confidential business
information, such as a manufacturing process. Please note that if you
include your name, contact information, or other information that
identifies you in the body of your objection, that information will be
posted on https://www.regulations.gov.
     If you want to submit an objection with confidential
information that you do not wish to be made available to the public,
submit the objection as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper objections submitted to the Dockets
Management Staff, FDA will post your objection, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2017-F-3717 for ``Food Additives Permitted for Direct Addition to
Food for Human Consumption; Vitamin D3 Final Rule.''
Received objections, those filed in a timely manner (see ADDRESSES),
will be placed in the docket and, except for those submitted as
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit an objection with
confidential information that you do not wish to be made publicly
available, submit your objections only as a written/paper submission.
You should submit two copies total. One copy will include the
information you claim to be confidential with a heading or cover note
that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We
will review this copy, including the claimed confidential information,
in our consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Judith Kidwell, Center for Food Safety
and Applied Nutrition (HFS-265), Food and Drug Administration, 5001
Campus Dr., College Park, MD 20740-3835,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of July 26, 2017 (82 FR 34615), amended
August 22, 2017 (82 FR 39711), we announced that we filed a food
additive petition (FAP 7A4818) submitted on behalf of the Juice
Products Association by Hogan

Lovells US LLP, Columbia Square, 555 Thirteenth Street NW, Washington,
DC 20004. The petition proposed to amend the food additive regulations
in Sec.  172.380 (21 CFR 172.380), Vitamin D3, to replace
the currently specified minimum RDI percentage values of calcium in
calcium-fortified 100 percent fruit juices and fruit juice drinks with
absolute values. Specifically, Sec.  172.380(c)(1) currently provides
for the use of vitamin D3 at a level not to exceed 100
International Units (IU) per 240 milliliters (mL) in 100 percent fruit
juices that are fortified with greater than or equal to 33 percent of
the RDI of calcium per 240 mL, excluding fruit juices that are
specifically formulated or processed for infants. In addition, Sec.
172.380(c)(2) provides for the use of up to 100 IU of vitamin
D3 per 240 mL in fruit juice drinks that are fortified with
greater than or equal to 10 percent of the RDI of calcium per 240 mL,
excluding fruit juice drinks that are specifically formulated or
processed for infants. The petitioner proposed to replace the RDI
percentage values of calcium in 100 percent fruit juices and fruit
juice drinks in these regulations with the absolute values of added
calcium of 330 milligrams (mg) and 100 mg per 240 mL, respectively. The
petitioner also requested that we update the reference for
specifications for vitamin D3 in Sec.  172.380(b) from the
9th edition of the Food Chemicals Codex (FCC 9) to the 10th edition
(FCC 10).

II. Evaluation of Petition

    Section 409(i) of the Federal Food, Drug, and Cosmetic Act (FD&C
Act) (21 U.S.C. 348(i)) states that we shall, by regulation, establish
the procedure for amending or repealing a food additive regulation, and
that this procedure shall conform to the procedure provided in section
409 of the FD&C Act. Our regulations specific to administrative actions
for food additives provide that the Commissioner of Food and Drugs, on
his own initiative or on the petition of any interested person, may
propose the issuance of a regulation amending or repealing a regulation
pertaining to a food additive (Sec.  171.130(a) (21 CFR 171.130(a))).
The regulations further provide that any such petition must include an
assertion of facts, supported by data, showing that new information
exists with respect to the food additive or that new uses have been
developed or old uses abandoned, that new data are available as to
toxicity of the chemical, or that experience with the existing
regulation or exemption may justify its amendment or repeal. New data
submitted as a food additive petition must be furnished in the form
specified in 21 CFR 171.1 and 171.100 for submitting such petitions
(Sec.  171.130(b)).
    In the Federal Register of February 27, 2003 (68 FR 9000), we
issued the regulations at Sec.  172.380(c)(1) and (2) permitting the
use of vitamin D3 in calcium fortified 100 percent fruit
juices and fruit juice drinks. We took that action in response to a
food additive petition (FAP 2A4734) from the Minute Maid Co. (Minute
Maid). Minute Maid petitioned for vitamin D3 to be allowed
to be added to calcium-fortified 100 percent fruit juices and fruit
juice drinks so that the calcium and vitamin D levels are comparable to
the levels in milk. When we issued these regulations in 2003, the RDI
for calcium was 1,000 mg; however, in the Federal Register of May 27,
2016 (81 FR 33742), we issued a final rule which, among other things,
redefined the RDI of calcium for adults and children 4 years of age and
older to 1,300 mg (21 CFR 101.9(c)(8)(iv)). Because of the change in
the RDI for calcium, the minimum level of added calcium in 100 percent
fruit juice that may be fortified with vitamin D3 increased
from 330 mg to 430 mg and in fruit juice drinks from 100 mg to 130 mg.
    The Juice Products Association stated that the proposed revision of
Sec.  172.380 to specify absolute values of calcium on a mg/mL basis
rather than a percentage of RDI is needed to maintain the relative
parity between fortified 100 percent fruit juices and fruit juice
drinks and many dairy products. Without this change, the petitioner
stated that 100 percent fruit juices with vitamin D3 would
have higher calcium levels than milk. The petitioner also stated that
the higher levels of calcium resulting from the redefined RDI for
calcium present formulation challenges and may adversely impact the
taste of the juice or juice drink, which could deter consumers from
selecting calcium and vitamin D fortified juices. Therefore, the
petitioner proposed that Sec.  172.380 be amended to express the
allowable added calcium levels on a mg basis consistent with the
calcium levels before the revision of the RDI for calcium. In doing so,
the allowable levels of calcium and vitamin D in 100 percent fruit
juices and juice drinks would again be comparable to the levels in
milk.
    Because the petitioner sought to revise the existing regulation to
restore the amount of calcium fortification required to levels on par
with milk, without introducing new uses for vitamin D3 or
changing the levels of vitamin D3 and calcium that were
considered when the regulations were established, there is no increase
in dietary exposure to vitamin D3 or to calcium. Therefore,
we have determined that there are no safety concerns as a result of the
proposed amendment.
    Additionally, the current regulation for the use of vitamin
D3 in food (Sec.  172.380) indicates that the additive must
meet the specifications in the 9th edition of the Food Chemicals Codex
(FCC 9). The petitioner requested that we update the specifications for
vitamin D3 in Sec.  172.380 by replacing the existing FCC 9
reference with the 10th edition of the Food Chemicals Codex (FCC 10),
the most recent edition at the time the petition was submitted. The
specifications for vitamin D3 in FCC 10 are identical to
those in FCC 9. However, since we received the petition, FCC has been
updated to the 11th edition (FCC 11). The specifications for vitamin
D3 in FCC 11 are identical to those in FCC 10. Therefore, we
are amending Sec.  172.380 by adopting the specifications for vitamin
D3 in FCC 11 in place of FCC 9, because FCC 11 is the most
current version.

III. Incorporation by Reference

    FDA is incorporating by reference the monograph from Food Chemicals
Codex, 11th ed., 2018, pp. 1243-1244 (vitamin D3), which is
approved by the Director of the Office of the Federal Register. You may
purchase a copy of the material from the United States Pharmacopeial
Convention, 12601 Twinbrook Pkwy., Rockville, MD 20852, 1-800-227-8772,
http://www.usp.org/. Copies also may be examined at FDA's Main Library,
10903 New Hampshire Ave., Bldg. 2, Third Floor, Silver Spring, MD
20993,<PHONE_NUMBER>.
    The FCC monograph establishes the standard for purity and identity
for vitamin D3. The monograph provides specifications and
analytical methodologies used to identify the substance and establish
acceptable purity criteria. To ensure that only food grade vitamin
D3 is used in foods listed in Sec.  172.380, the additive
must meet the specifications and identity in the FCC monograph.

IV. Conclusion

    Based on data and information in the petition, we conclude that
amending the food additive regulations in the regulation for vitamin
D3 to replace the current RDI percentage values of calcium
in 100 percent fruit juices and fruit juice drinks with absolute values
is safe and appropriate. Thus, the RDI percentage values of calcium in
100 percent fruit juices and fruit juice drinks in these regulations
are replaced with the absolute values of added calcium of

330 mg and 100 mg per 240 mL, respectively. Consequently, we are
amending the food additive regulations as set forth in this document.
    Additionally, the current regulation for the use of vitamin
D3 in food (Sec.  172.380) indicates that the additive must
meet the specifications in FCC 9. The more current version is FCC 11,
which contains specifications for vitamin D3 that are
identical to those in FCC 9. We are amending Sec.  172.380 by adopting
the specifications for vitamin D3 in FCC 11 in place of FCC
9.

V. Public Disclosure

    In accordance with Sec.  171.1(h) (21 CFR 171.1(h)), the petition
and the documents that we considered and relied upon in reaching our
decision to approve the petition will be made available for public
disclosure (see FOR FURTHER INFORMATION CONTACT). As provided in Sec.
171.1(h), we will delete from the documents any materials that are not
available for public disclosure.

VI. Analysis of Environmental Impact

    We previously considered the environmental effects of this rule, as
stated in the July 26, 2017, Federal Register notice of filing (82 FR
34615). We stated in the notice of filing that we had determined, under
21 CFR 25.30(i), that this action ``is of a type that does not
individually or cumulatively have a significant effect on the human
environment because the amendments are administrative in nature'' such
that neither an environmental assessment nor an environmental impact
statement is required. Upon further consideration, we determined that
FAP 7A4818 is not solely administrative in nature as this revision has
the potential to lead to manufacturing changes. Consequently, the
action being requested is neither a correction nor technical change and
the original categorical exclusion (21 CFR 25.30(i)) is not
appropriate. Therefore, we have determined under 21 CFR 25.32(k) that
this action is of a type that does not individually or cumulatively
have a significant effect on the human environment because the added
vitamin D3 and calcium will remain in the fruit juice and
fruit juice drinks through ingestion by consumers and neither food
additive is intended to replace macronutrients. Therefore, neither an
environmental assessment nor an environmental impact statement is
required.

VII. Paperwork Reduction Act of 1995

    This final rule contains no collection of information. Therefore,
clearance by the Office of Management and Budget under the Paperwork
Reduction Act of 1995 is not required.

VIII. Section 301(ll) of the Federal Food, Drug, and Cosmetic Act

    Our review of this petition was limited to section 409 of the FD&C
Act. This final rule is not a statement regarding compliance with other
sections of the FD&C Act. For example, section 301(ll) of the FD&C Act
(21 U.S.C. 331(ll)) prohibits the introduction or delivery for
introduction into interstate commerce of any food that contains a drug
approved under section 505 of the FD&C Act (21 U.S.C. 355), a
biological product licensed under section 351 of the Public Health
Service Act (42 U.S.C. 262), or a drug or biological product for which
substantial clinical investigations have been instituted and their
existence has been made public, unless one of the exemptions in section
301(ll)(1) to (4) of the FD&C Act applies. In our review of this
petition, we did not consider whether section 301(ll) of the FD&C Act
or any of its exemptions apply to food containing this additive.
Accordingly, this final rule should not be construed to be a statement
that a food containing this additive, if introduced or delivered for
introduction into interstate commerce, would not violate section
301(ll) of the FD&C Act. Furthermore, this language is included in all
food additive final rules and therefore should not be construed to be a
statement of the likelihood that section 301(ll) of the FD&C Act
applies.

IX. Objections

    If you will be adversely affected by one or more provisions of this
regulation, you may file with the Dockets Management Staff (see
ADDRESSES) either electronic or written objections. You must separately
number each objection, and within each numbered objection you must
specify with particularity the provision(s) to which you object, and
the grounds for your objection. Within each numbered objection, you
must specifically state whether you are requesting a hearing on the
particular provision that you specify in that numbered objection. If
you do not request a hearing for any particular objection, you waive
the right to a hearing on that objection. If you request a hearing,
your objection must include a detailed description and analysis of the
specific information you intend to present in support of the objection
in the event that a hearing is held. If you do not include such a
description and analysis for any particular objection, you waive the
right to a hearing on the objection.
    Any objections received in response to the regulation may be seen
in the Dockets Management Staff between 9 a.m. and 4 p.m., Monday
through Friday, and will be posted to the docket at https://www.regulations.gov.

List of Subjects in 21 CFR Part 172

    Food additives, Incorporation by reference, Reporting and
recordkeeping requirements.

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs, 21 CFR part
172 is amended as follows:

PART 172--FOOD ADDITIVES PERMITTED FOR DIRECT ADDITION TO FOOD FOR
HUMAN CONSUMPTION

0
1. The authority citation for part 172 continues to read as follows:

    Authority: 21 U.S.C. 321, 341, 342, 348, 371, 379e.

0
2. Amend Sec.  172.380 by revising paragraphs (b) and (c)(1) through
(2) to read as follows:

Sec.  172.380  Vitamin D3.

* * * * *
    (b) Vitamin D3 meets the specifications of ``Vitamin
D3,'', Food Chemicals Codex, 11th ed., copyright 2018, pp.
1243-1244, which is incorporated by reference. The Director of the
Office of the Federal Register approves this incorporation by reference
in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. You may obtain
copies from the United States Pharmacopeial Convention, 12601 Twinbrook
Pkwy., Rockville, MD 20852 (internet address http://www.usp.org).
Copies may be examined at the Food and Drug Administration's Main
Library, 10903 New Hampshire Ave., Bldg. 2, Third Floor, Silver Spring,
MD 20993,<PHONE_NUMBER>, or at the National Archives and Records
Administration (NARA). For information on the availability of this
material at NARA, call<PHONE_NUMBER>, or go to: http://www.archives.gov/federal-register/cfr/ibr-locations.html.
    (c) * * *
    (1) At levels not to exceed 100 International Units (IU) per 240
milliliters (mL) in 100 percent fruit juices (as defined under Sec.
170.3(n)(35) of this chapter) that are fortified with greater than or
equal to 330 milligrams (mg) of calcium per 240 mL, excluding fruit
juices that are specially formulated or processed for infants.
    (2) At levels not to exceed 100 IU per 240 mL in fruit juice drinks
(as defined under Sec.  170.3(n)(35) of this chapter) that

are fortified with greater than or equal to 100 mg of calcium per 240
mL, excluding fruit juice drinks that are specially formulated or
processed for infants.
* * * * *

    Dated: September 13, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-20375 Filed 9-19-18; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 75, Number 239 (Tuesday, December 14, 2010)]
[Notices]
[Page 77889]
[FR Doc No: 2010-31287]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-1949-DR; Docket ID FEMA-2010-0002]

Virgin Islands; Major Disaster and Related Determinations

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice of the Presidential declaration of a major
disaster for the Territory of the U.S. Virgin Islands (FEMA-1949-DR),
dated November 24, 2010, and related determinations.

DATES: Effective Date: November 24, 2010.

FOR FURTHER INFORMATION CONTACT: Peggy Miller, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street, SW.,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Notice is hereby given that, in a letter
dated November 24, 2010, the President issued a major disaster
declaration under the authority of the Robert T. Stafford Disaster
Relief and Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the
``Stafford Act''), as follows:

    I have determined that the damage in certain areas of the
Territory of the U.S. Virgin Islands resulting from severe storms,
flooding, rockslides, and mudslides associated with Tropical Storm
Tomas during the period of November 8-12, 2010, is of sufficient
severity and magnitude to warrant a major disaster declaration under
the Robert T. Stafford Disaster Relief and Emergency Assistance Act,
42 U.S.C. 5121 et seq. (the ``Stafford Act''). Therefore, I declare
that such a major disaster exists in the Territory of the U.S.
Virgin Islands.
    In order to provide Federal assistance, you are hereby
authorized to allocate from funds available for these purposes such
amounts as you find necessary for Federal disaster assistance and
administrative expenses.
    You are authorized to provide Public Assistance in the
designated areas and Hazard Mitigation throughout the Territory of
the U.S. Virgin Islands. Consistent with the requirement that
Federal assistance is supplemental, any Federal funds provided under
the Stafford Act for Public Assistance and Hazard Mitigation will be
limited to 75 percent of the total eligible costs.
    Further, you are authorized to make changes to this declaration
for the approved assistance to the extent allowable under the
Stafford Act.

    The Federal Emergency Management Agency (FEMA) hereby gives notice
that pursuant to the authority vested in the Administrator, under
Executive Order 12148, as amended, Philip E. Parr, of FEMA is appointed
to act as the Federal Coordinating Officer for this major disaster.
    The following islands of the Territory of the U.S. Virgin Islands
have been designated as adversely affected by this major disaster:

    The island of St. Croix for Public Assistance.
    All islands in the Territory of the U.S. Virgin Islands are
eligible to apply for assistance under the Hazard Mitigation Grant
Program.

The following Catalog of Federal Domestic Assistance Numbers (CFDA)
are to be used for reporting and drawing funds: 97.030, Community
Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034, Disaster Unemployment
Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048,
Disaster Housing Assistance to Individuals and Households In
Presidentially Declared Disaster Areas; 97.049, Presidentially
Declared Disaster Assistance--Disaster Housing Operations for
Individuals and Households; 97.050, Presidentially Declared Disaster
Assistance to Individuals and Households--Other Needs; 97.036,
Disaster Grants--Public Assistance (Presidentially Declared
Disasters); 97.039, Hazard Mitigation Grant.

W. Craig Fugate,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2010-31287 Filed 12-13-10; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register Volume 85, Number 227 (Tuesday, November 24, 2020)]
[Notices]
[Pages 75070-75071]
[FR Doc No: 2020-25894]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[SEC File No. 270-185, OMB Control No. 3235-0238]

Proposed Collection; Comment Request

Extension:
    Form N-6F

    Notice is hereby given that, pursuant to the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.) the Securities and Exchange
Commission (the ``Commission'') is soliciting comments on the
collection of information summarized below. The Commission plans to
submit this existing collection of information to the Office of
Management and Budget for extension and approval.
    The title for the collection of information is ``Form N-6F (17 CFR
274.15), Notice of Intent to Elect to be Subject to Sections 55 through
65 of the Investment Company Act of 1940.'' The purpose of Form N-6F is
to notify the Commission of a company's intent to file a notification
of election to become subject to Sections 55 through 65 of the
Investment Company Act of 1940 (15 U.S.C. 80a-1 et seq.) (``1940
Act''). Certain companies may have to make a filing with the Commission
before they are ready to elect to be regulated as a business
development company.\1\ A company that is excluded from the definition
of ``investment company'' by Section 3(c)(1) because it has fewer than
one hundred shareholders and is not making a public offering of its
securities may lose such an exclusion solely because it proposes to
make a public offering of securities as a business development company.
Such company,

under certain conditions, would not lose its exclusion if it notifies
the Commission on Form N-6F of its intent to make an election to be
regulated as a business development company. The company only has to
file a Form N-6F once.
---------------------------------------------------------------------------

    \1\ A company might not be prepared to elect to be subject to
Sections 55 through 65 of the 1940 Act because its capital structure
or management compensation plan is not yet in compliance with the
requirements of those sections.
---------------------------------------------------------------------------

    The Commission estimates that on average approximately 4 companies
file these notifications each year. Each of those companies need only
make a single filing of Form N-6F. The Commission further estimates
that this information collection imposes burden of 0.5 hours, resulting
in a total annual PRA burden of 2 hours. Based on the estimated wage
rate, the total cost to the industry of the hour burden for complying
with Form N-6F would be approximately $736.
    The collection of information under Form N-6F is mandatory. The
information provided under the form is not kept confidential. An agency
may not conduct or sponsor, and a person is not required to respond to,
a collection of information unless it displays a currently valid OMB
control number.
    Written comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information will
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the collection of information; (c) ways to enhance the
quality, utility, and clarity of the information collected; and (d)
ways to minimize the burden of the collection of information on
respondents, including through the use of automated collection
techniques or other forms of information technology. Consideration will
be given to comments and suggestions submitted in writing within 60
days of this publication.
    Please direct your written comments to David Bottom, Director/Chief
Information Officer, Securities and Exchange Commission, C/O Cynthia
Roscoe, 100 F Street NE, Washington, DC 20549; or send an email to:
<EMAIL_ADDRESS>
    Dated: November 18, 2020.
J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2020-25894 Filed 11-23-20; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 182 (Wednesday, September 19, 2012)]
[Notices]
[Pages 58133-58134]
[FR Doc No: 2012-23086]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9729-6]

Environmental Financial Advisory Committee; Request for
Nominations of Candidates to the Environmental Financial Advisory Board

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The United States Environmental Protection Agency (EPA)
invites nominations of qualified candidates to be considered for
appointments to fill vacancies on the Environmental Financial Advisory
Board (the Board or EFAB). The Board seeks to maintain diverse
representation across all workforce sectors and geographic locations.
Nominees should demonstrate experience in any of the following areas:
Environmental technology investments; commercial banking, local utility
management and finance, green infrastructure financing, sustainable
community partnerships; environmental insurance, and water and
wastewater infrastructure and program financing. Nominees are
encouraged who live and work in the southeastern, southwestern,
western, and northwestern parts of the United States.
    EPA values and welcomes diversity. In an effort to obtain a diverse
pool of candidates, EPA encourages nominations of women and men of all
racial and ethnic groups. In addition to this notice, other sources may
be utilized in the solicitation of nominees. The deadline for receiving
nominations is Monday, October 15, 2012. Appointments will be made by
the Deputy Administrator of the Environmental Protection Agency and
will be announced in March 2013. Nominee qualifications will be
assessed under the mandates of the Federal Advisory Committee Act,
which requires Committees to maintain diversity across a broad range of
constituencies, sectors, and groups.

DATES: Nominations should be submitted in time to arrive no later than
October 15, 2012.
    Background Information: The Environmental Financial Advisory Board
was chartered in 1989 under the Federal Advisory Committee Act to
provide advice and recommendations to EPA on the following issues:
     Reducing the cost of financing environmental facilities
and discouraging polluting behavior;
     Creating incentives to increase private investment in the
provision of environmental services and removing or reducing
constraints on private involvement imposed by current regulations;
     Developing new and innovative environmental financing
approaches and supporting and encouraging the use of cost-effective
existing approaches;
     Identifying approaches specifically targeted to small/
disadvantaged community financing;
     Increasing the capacity of state and local governments to
carry out their respective environmental programs under current Federal
tax laws;
     Analyzing how new technologies can be brought to market
expeditiously;
     Increasing the total investment in environmental
protection of public, and private environmental resources to help ease
the environmental financing challenge facing our nations.
    The Board meets two times each calendar year (two days per meeting)
at different locations within the continental United States. Board
members typically contribute approximately 1-3 hours per month to the
Board's work. The Board's membership services are voluntary and the
Agency is unable to provide honoraria or compensation, according to
FACA guidelines. However, Board members may receive travel and per diem
allowances, where appropriate and in accordance with Federal Travel
Regulations for invitational travelers.
    Evaluation Criteria: The following criteria will be used to
evaluate nominees:
    [ssquf] Residence in the continental United States;
    [ssquf] Professional knowledge of, and experience with,
environmental financing activities;
    [ssquf] Senior level-experience that fills a gap in Board
representation, or brings a new and relevant dimension to its
deliberations;
    [ssquf] Demonstrated ability to work in a consensus-building
process with a wide range of representatives from diverse
constituencies; and
    [ssquf] Willingness to serve a two-year term as an active-
contributing member, with possible re-appointment to a second term.
    Nominations for membership must include a resume describing the
professional and educational qualifications of the nominee as well as
expertise/experience. Contact details should include full name and
title, business mailing address, telephone, fax, and email address. A
supporting letter of endorsement is encouraged but not required.
    Addresses/For Further Information Contact: Submit nomination
materials by postal mail, electronic mail, or fax to: Pamela Scott,
Membership Coordinator, Environmental Financial Advisory Board, EPA,
Office of the Chief Financial Officer, 1200 Pennsylvania Avenue NW.
(2731A), Washington, DC 20460; or email<EMAIL_ADDRESS>phone
202-564-6368; or fax<PHONE_NUMBER>.

    Dated: September 11, 2012.
Timothy P. McProuty,
Acting Director, Center for Environmental Finance, Office of the Chief
Financial Officer.
[FR Doc. 2012-23086 Filed 9-18-12; 8:45 am]
BILLING CODE 6560-50-P